MMI Receives FDA IDE Approval for First Robotic Microsurgical Study Targeting Alzheimer’s Disease
The REMIND study will evaluate the safety and effectiveness of the Symani® Surgical System for restoring lymphatic drainage pathways in Alzheimer’s patients.